Bio-medical Waste Management during covid-19: A comprehensive review of global scenario

Abstract

BACKGROUND
The increased volumes of health care waste from the COVID-19 response exposed cracks in waste
management systems everywhere (1). Defining Bio-Medical Waste (BMW) in the COVID-19 context extends
to waste generated during treatment, diagnosis, quarantine, and home care of COVID19 patients. Solid
waste is considered infectious only if it is contaminated by body fluids and secretions of COVID-19 patients
(like tissues, masks, gloves, etc.); otherwise, uncontaminated solid waste is handled as per Solid Waste
Management Rules 2016 (2).